Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
LiveOne (Nasdaq: LVO) Expands Web3/Crypto Advisory Board, Bringing Back Andy Vick
-
Xunlei Limited Schedules 2025 Unaudited Second Quarter Earnings Release on August 14, 2025
-
Milestone Achievement for Hospital Using Catheter Precision’s VIVO System
-
Nualtis Announces Strategic Partnership with OrthoNu for Innovative Orthodontic Care Products
-
Route 92 Medical Files Patent Infringement Suit Against Balt
-
Izotropic Launches Podcast Episode #1: Beyond the Mammogram: Rethinking the Future of Breast Imaging
-
Geotab at 25: Driving the Future of Connected Vehicles
-
Super League Sets Second Quarter 2025 Earnings Date, August 14, 2025
-
RAPT Therapeutics Reports Second Quarter 2025 Financial Results
-
Ascent Solar Technologies Establishes Rapid Thin-Film PV Delivery Process to Provide Customized Space Solar Products Ahead of Schedule on Mission Enabling Timelines
-
vTv Therapeutics Announces First Study Participant Randomized in CATT1 Phase 3 Trial of Cadisegliatin in Type 1 Diabetes
-
Fly-E Group, Inc. Enters the South American Market with First Store Grand Opening in Mexico and Strategic Partnership with TECHNOLOGIES E-SOLOMO
-
Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL
-
Apterra Infrastructure Capital Appoints David Law to Board of Directors
-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2025 and Declaration of Distributions on Common Stock for the Months Ending October
-
OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2025
-
Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
GCM Grosvenor Reports Second Quarter 2025 Earnings Results, with Year-To-Date Fundraising Increasing 52% Year-Over-Year, Year-to-Date GAAP Net Income, Fee-Related Earnings and Adjusted Net Income Incr
-
Zyter|TruCare Unveils Zyter Symphony: Orchestrated AI Platform to Reimagine Enterprise Workflows
-
Fiverr Releases Its 2024 Impact Report
-
Stryker declares an $0.84 per share quarterly dividend
-
Anteriad Celebrates 25 Years of Growth for B2B Marketers
-
Labrynth Launches the Red Tape Index to Help America Build Smarter, Faster
-
UroGen Pharma Expands Commercial Portfolio with Launch of ZUSDURI™ and Reports Second Quarter 2025 Financial Results
-
Rocket Doctor Strengthens Access to Care Across Ontario as ER Closures and Physician Shortages Rise
-
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
-
Remote Monitoring and Control Provider Acorn’s Q2’25 EPS of $0.28, Up 155% on 55% Revenue Growth; Investor Call Today at 11 a.m. ET
-
Form 8.3 - Assura Plc
-
Form 8.3 - Apax Global Alpha Limited
-
Bitget Protection Fund Reaches Record High of $779.7M in July 2025, Reinforcing Commitment to User Asset Safety
-
Kinetic Seas Launches Skilliks: A Unified Platform to Support the Full Lifecycle of AI-Driven Software Projects
-
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
-
illumin Reports Second Quarter 2025 Financial Results
-
AI Prop Launches Global Raffle Contest with Dubai Trip and Cash Prizes
-
Bitget Wallet Launches USD-Based Crypto Card in Brazil, Eye Latin America Expansion
-
Global Medical Technology Leader Selects Kneat
-
Nortech Systems Reports Second Quarter Results
-
Cronos Group Reports 2025 Second Quarter Results
-
City of New Bern Selects Hansen to Enable Smarter City Experiences with Hansen MDM
-
Sunrise Realty Trust, Inc. Announces Financial Results for the Second Quarter 2025
-
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
-
SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
-
TEGNA Inc. Reports Second Quarter 2025 Results and Provides Third Quarter Guidance
-
Parker Reports Fiscal 2025 Fourth Quarter and Full Year Results
-
Knight Therapeutics Reports Second Quarter 2025 Results
-
Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
-
Kelly Reports Second-Quarter 2025 Earnings
-
Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress
-
Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025
-
Clarence Square Revitalization Activates Key Pedestrian Corridor and Green Space in Downtown Toronto
